First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Short Interest Up 325.0% in December

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) was the target of a significant increase in short interest in December. As of December 31st, there was short interest totaling 35,837 shares, an increase of 325.0% from the December 15th total of 8,433 shares. Based on an average daily trading volume, of 16,981 shares, the days-to-cover ratio is currently 2.1 days. Currently, 0.6% of the shares of the stock are sold short. Currently, 0.6% of the shares of the stock are sold short. Based on an average daily trading volume, of 16,981 shares, the days-to-cover ratio is currently 2.1 days.

Institutional Trading of First Trust NYSE Arca Biotechnology Index Fund

Several large investors have recently modified their holdings of FBT. Russell Investments Group Ltd. raised its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 7,900.0% during the 3rd quarter. Russell Investments Group Ltd. now owns 160 shares of the company’s stock worth $29,000 after purchasing an additional 158 shares during the last quarter. Rossby Financial LCC increased its position in First Trust NYSE Arca Biotechnology Index Fund by 160.0% during the third quarter. Rossby Financial LCC now owns 169 shares of the company’s stock worth $31,000 after buying an additional 104 shares in the last quarter. Capital Investment Advisory Services LLC raised its holdings in shares of First Trust NYSE Arca Biotechnology Index Fund by 63.1% in the third quarter. Capital Investment Advisory Services LLC now owns 181 shares of the company’s stock worth $32,000 after acquiring an additional 70 shares during the last quarter. Hazlett Burt & Watson Inc. lifted its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 101.0% in the third quarter. Hazlett Burt & Watson Inc. now owns 201 shares of the company’s stock valued at $36,000 after acquiring an additional 101 shares in the last quarter. Finally, Founders Financial Alliance LLC acquired a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund during the third quarter valued at $61,000.

First Trust NYSE Arca Biotechnology Index Fund Stock Down 0.4%

Shares of First Trust NYSE Arca Biotechnology Index Fund stock traded down $0.80 on Tuesday, hitting $212.35. The company’s stock had a trading volume of 7,094 shares, compared to its average volume of 36,337. First Trust NYSE Arca Biotechnology Index Fund has a 52-week low of $141.38 and a 52-week high of $220.14. The firm has a fifty day moving average price of $208.04 and a 200-day moving average price of $186.44. The company has a market capitalization of $1.36 billion, a P/E ratio of 21.72 and a beta of 0.65.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.